The health care and societal costs of inherited retinal diseases in Australia: a microsimulation modelling study

Deborah Schofield(The University of Sydney), Robyn V. Jamieson(The University of Sydney), Alan Ma(The University of Sydney), Natalie Hart(Impact), Joshua Kraindler(Macquarie University), Owen Tan(The University of Sydney), Rupendra Shrestha(Macquarie University), Sarah West(Macquarie University), L. Y. Tan(The University of Sydney), John Grigg(Children's Medical Research Institute)

The Medical Journal of Australia

June 10, 2023

10.5694/mja2.51997

Cited by 22

Related Papers

A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial

|International Journal of Obesity|2012|2.1k

Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions

|JAMA Pediatrics|2017|335

Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement

|Genetics in Medicine|2017|246

Feasibility of Ultra-Rapid Exome Sequencing in Critically Ill Infants and Children With Suspected Monogenic Conditions in the Australian Public Health Care System

|JAMA|2020|235

Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders

|Genetics in Medicine|2018|200